Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies (Q33661359)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies |
scientific article |
Statements
1 reference
Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies (English)
1 reference
Campbell Howard
1 reference
Adele Noe
1 reference
Andrej Skerjanec
1 reference
Margaret Wernsing
1 reference
Monica Ligueros-Saylan
1 reference
Tom Thuren
1 reference
17 May 2014
1 reference
1 reference
13
1 reference
94
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference